Navigation Links
SRI International receives $100,000 Grand Challenges Explorations grant
Date:5/6/2009

MENLO PARK, Calif. May 6, 2008 SRI International announced today that it has received a US$100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project conducted by Krishna Kodukula, Ph.D., executive director of SRI International's Center for Advanced Drug Research (CADRE) in Shenandoah Valley, Virginia and Amit Galande, Ph.D., associate director of Proteomics and Protein Biochemistry at CADRE, titled "Combating Antibiotic Resistance in Tuberculosis."

SRI's project is one of 81 grants announced by the Gates Foundation in the second funding round of Grand Challenges Explorations, an initiative to help scientists around the world explore bold and largely unproven ways to improve health in developing countries. The grants were provided to scientists in 17 countries on six continents, selected from more than 3,000 proposals received by the Foundation in this highly competitive round of funding.

To receive funding, Kodukula and Galande showed in a two-page application how their idea falls outside current scientific paradigms and might lead to significant advances in global health. SRI's research project will address the problem of antibiotic resistance and the need for broad-spectrum antibiotics. Resistant strains of tuberculosis will initially be screened. Based on those results, the project will be expanded to include other pathogenic bacteria that can lead to the development of the next generation of antibiotics.

Since proteins that are antibiotic targets are prone to mutations that can result in antibiotic resistance, researchers will target non-protein components of cells. Small organic molecule metabolites that are essential for the growth and survival of pathogenic bacteria will be used as targets for antibiotic discovery.

"Antibiotic resistance is a serious public health problem around the world," said Dr. Kodukula. "It can change the course of infections that are treatable and lead to diseases that are difficult to cure. Drug resistant strains of tuberculosis pose a grave threat to global health because treatment options are becoming severely limited."

"The winners of these grants are doing truly exciting and innovative work," said Dr. Tachi Yamada, president of the Gates Foundation's Global Health Program. "I'm optimistic that some of these exploratory projects will lead to life-saving breakthroughs for people in the world's poorest countries."


'/>"/>

Contact: Dina Basin
dina.basin@sri.com
650-859-3845
SRI International
Source:Eurekalert

Related biology news :

1. International team finds key gene that allows plants to survive drought
2. BIO-key(R) International Showcasing Biometric Identification Technology at 2009 RSA Conference
3. Canadian biomedical engineering pioneer receives international award
4. Major international study challenges notions of how genes are controlled in mammals
5. International honor for University of East Anglia ocean researcher
6. Biomedical researchers invited to design experiments for the International Space Station
7. International climate change researchers meet, review latest findings
8. International prize for Nottingham spine research
9. Uvalde Center water research could have national, international applications
10. Anatomical Science International joins Springers publishing program
11. UABs Lisa Guay-Woodford earns top international nephrology prize
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... , Spanien, 27. Februar 2017  EyeLock LLC, ein ... wird seine erstklassige biometrische Lösung zur Iris-Erkennung ... mit X16 LTE auf dem Mobile World ... am Qualcomm-Stand in Halle 3, Stand 3E10, ... die Sicherheitsplattform Qualcomm Haven™ – eine Kombination ...
(Date:2/24/2017)... , Feb. 24, 2017  EyeLock LLC, a leader ... its elite iris biometric solution on the latest ... LTE at Mobile World Congress 2017 (February ... Booth in Hall 3, Stand 3E10. ... Qualcomm Haven™ security platform—a combination of hardware, ...
(Date:2/21/2017)... -- Der weltweite Biobanking-Sektor wird bis zum ... mit mehr als 50 Vertretern aus verschiedenen Branchen wurde aber ... diese Prognose zu realisieren. ... Zu den Schwierigkeiten für ... für die Biobank, die Implementierung Zeit sparender Technologien, ein ...
Breaking Biology News(10 mins):
(Date:3/24/2017)... , March 24, 2017  Infectex Ltd., a ... today announced positive results of a Phase 2b-3 clinical ... regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). SQ109 ... at Sequella, Inc. ( USA ) and ... A total of 140 patients were enrolled in a ...
(Date:3/24/2017)... -- On Thursday, March 23, 2017, the ... 0.07%; the Dow Jones Industrial Average edged 0.02% lower, ... at 2,345.96, marginally dropping 0.11%. US markets saw a ... sectors finished in red, and 1 sector ended flat ... coverage on the following Biotechnology equities: BioDelivery Sciences International ...
(Date:3/23/2017)... ... March 23, 2017 , ... AxioMed ... both viscous and elastic characteristics when deformed, which is identical to how the ... gently absorb compressive forces and return to its natural state along a hysteresis ...
(Date:3/23/2017)... March 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) ... immune therapies for solid tumor cancers, today announced ... financing it announced last Friday, March 17, 2017. ... institutional investors securities totaling 28,843,692 shares, comprised of ... 10,000,000 shares of Class C Warrants pre-funded at ...
Breaking Biology Technology: